cancer research technology

Brain Cancer Patients With ‘T allele’ Live 5 Months Longer

The T allele is also predictive of a positive response to the standard cancer treatment, temozolomide.

Clearbridge & LIDE Launch China’s First CTC Hub

Clearbridge Biomedics has partnered LIDE Biotech to bring circulating tumor cell isolation technology to China.

Astellas & Cancer Research UK Team Up In Fight Against Cancer

The partnership between Astellas and Cancer Research Technology will begin with the development of drugs for pancreatic cancer targeting autophagy.